Member Info for mcleod

positive trial result in latest RNS Ongoing good progress from an early stage pharm which is excellent

not much point increasing revenue if you dont increase profits or EBITDA looks like woodford topped up with latest RNS but given fall probably averaging down I sold yesterday as soon as news came out and am glad I did. Buffett said never lose your capital as the first principle

These results were interesting as actually quite good growth of business. However, the lack of actual profit growth would appear to be the problem. Someone presumably hasn't kept a grip on costs or margins are under pressure - surely most businesses make more money for additional sales as basic costs are covered? Suspect have a lot further to fall as confidence gone

When are results out?

this is an early stage pharma so likely to be some setbacks interesting 250,000 share buys x 2 today

interesting company I can see GSK making a play for this with its new vaccine business